NBY Financial Facts
Other income (expense), net: -52KOperating income (loss): -2.01M
See Full Income Statement
TOTAL ASSETS: 15.14M
Total current liabilities: 3.73M
See Full Balance Sheet
NovaBay Pharma (NBY) Earnings
|
Expand Research on NBY
| Next EPS Date | N/A | EPS Growth Rate | -270.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -71.0% | Revenue Growth Rate | -14.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | +18.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/12/10  |
Q310 | -$0.07 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 5/16/11 | Q111 | -$0.08 | -$0.05 | -$0.03 | $2.5M | $2.22M | N/A | | | Details | |
| 8/10/11 | Q211 | $0.02 | -$0.10 | +$0.12 | N/A | $2.13M | N/A | | | Details | |
| 3/27/12 | Q411 | -$0.13 | N/A | N/A | $1.23M | $3.04M | N/A | | | Details | |
| 8/9/12 | Q212 | -$0.08 | -$0.08 | $0.00 | $871K | $1.71M | N/A | | | Details | |
| 11/1/12 | Q312 | $0.00 | -$0.04 | +$0.04 | $3.64M | $3.08M | N/A | | | Details | |
| 3/14/13 | Q412 | -$0.08 | -$0.09 | +$0.01 | N/A | $1.5M | N/A | | | Details | |
| 5/2/13 | Q113 | -$0.11 | -$0.07 | -$0.04 | N/A | $1.18M | N/A | | | Details |
